Planning and Evaluation

规划与评估

基本信息

  • 批准号:
    8804776
  • 负责人:
  • 金额:
    $ 5.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-02-01 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

PLANNING AND EVALUATION Project Summary Dr. Corey sets the overarching vision for the center. To accomplish this he engages internal and external leaders, committees and individuals to help chart the future directions, plans and strategic investments for the center. Planning is achieved through both formal and informal mechanisms. The same approach is applied to evaluation, so that leadership can assess how effectively it is achieving the center's goals and determine whether mid-course changes are needed. This planning and evaluation process has led to timely and successful implementation of new strategies and changes in the organization and direction of cancer research conducted at the Consortium. The Specific Aims of Planning and Evaluation are to: 1. Provide an effective structure that engages all Consortium partners in planning and evaluation activities such that institutional objectives are well aligned with common Consortium cancer research objectives. 2. Support and maximize the value of internal and external Consortium mechanisms (internal committees and external advisors) to identify areas of greatest strategic importance to the Consortium and their associated resource requirements, and dedicate sufficient leadership and institutional and CCSG funds to achieve measurable success. 3. Provide structure for ongoing evaluation of progress toward Consortium objectives. Major areas of emphasis during the new project period are to further develop solid tumor translational research; improve coordination and consistency of clinical trials support across the center; build biomedical informatics capabilities; expand research in the catchment area and with underserved populations; and build research capacity in cancer health economics, global oncology and obesity. 4. Engage Consortium members in identifying new areas of scientific opportunity, through provision of CCSG and other funds to support scientific symposia and workshops on emerging research areas.
计划与评估

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lawrence Corey其他文献

Lawrence Corey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lawrence Corey', 18)}}的其他基金

PPE Request
个人防护装备要求
  • 批准号:
    10582490
  • 财政年份:
    2023
  • 资助金额:
    $ 5.23万
  • 项目类别:
Personal Protective Equipment for Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies
用于 COVID-19 相关疫苗和治疗临床试验和临床研究资源的个人防护装备
  • 批准号:
    10252679
  • 财政年份:
    2020
  • 资助金额:
    $ 5.23万
  • 项目类别:
HVTN 405/HPTN 1901 Characterizing SARS-CoV-2-specific immunity in convalescent individuals
HVTN 405/HPTN 1901 表征恢复期个体的 SARS-CoV-2 特异性免疫力
  • 批准号:
    10167020
  • 财政年份:
    2020
  • 资助金额:
    $ 5.23万
  • 项目类别:
Personal Protective Equipment for Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies
用于 COVID-19 相关疫苗和治疗临床试验和临床研究资源的个人防护装备
  • 批准号:
    10225246
  • 财政年份:
    2020
  • 资助金额:
    $ 5.23万
  • 项目类别:
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
利用组织驻留记忆 T 细胞进行疱疹病毒感染的免疫治疗
  • 批准号:
    9926222
  • 财政年份:
    2018
  • 资助金额:
    $ 5.23万
  • 项目类别:
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
利用组织驻留记忆 T 细胞进行疱疹病毒感染的免疫治疗
  • 批准号:
    10409768
  • 财政年份:
    2018
  • 资助金额:
    $ 5.23万
  • 项目类别:
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
利用组织驻留记忆 T 细胞进行疱疹病毒感染的免疫治疗
  • 批准号:
    10593354
  • 财政年份:
    2018
  • 资助金额:
    $ 5.23万
  • 项目类别:
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
利用组织驻留记忆 T 细胞进行疱疹病毒感染的免疫治疗
  • 批准号:
    10160756
  • 财政年份:
    2018
  • 资助金额:
    $ 5.23万
  • 项目类别:
Developmental Funds
发展基金
  • 批准号:
    8804777
  • 财政年份:
    2015
  • 资助金额:
    $ 5.23万
  • 项目类别:
Administration
行政
  • 批准号:
    8804775
  • 财政年份:
    2015
  • 资助金额:
    $ 5.23万
  • 项目类别:

相似海外基金

UF Health Cancer Center Support Grant - Training Navigator Supplement
佛罗里达大学健康癌症中心支持补助金 - 培训导航补充
  • 批准号:
    10892335
  • 财政年份:
    2023
  • 资助金额:
    $ 5.23万
  • 项目类别:
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
乔治城大学隆巴迪综合癌症中心支持补助金
  • 批准号:
    10771760
  • 财政年份:
    2023
  • 资助金额:
    $ 5.23万
  • 项目类别:
University of Florida Health Cancer Center Support Grant
佛罗里达大学健康癌症中心支持补助金
  • 批准号:
    10625750
  • 财政年份:
    2023
  • 资助金额:
    $ 5.23万
  • 项目类别:
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
乔治城大学隆巴迪综合癌症中心支持补助金
  • 批准号:
    10619774
  • 财政年份:
    2022
  • 资助金额:
    $ 5.23万
  • 项目类别:
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
乔治城大学隆巴迪综合癌症中心支持补助金
  • 批准号:
    10405729
  • 财政年份:
    2022
  • 资助金额:
    $ 5.23万
  • 项目类别:
Cancer Center Support Grant
癌症中心支持补助金
  • 批准号:
    10643036
  • 财政年份:
    2022
  • 资助金额:
    $ 5.23万
  • 项目类别:
University of Colorado Cancer Center Support Grant - CTRAC Supplement Yr 02
科罗拉多大学癌症中心支持补助金 - CTRAC 补充第 02 年
  • 批准号:
    10439981
  • 财政年份:
    2021
  • 资助金额:
    $ 5.23万
  • 项目类别:
Abramson Cancer Center Support Grant.
艾布拉姆森癌症中心支持拨款。
  • 批准号:
    10367691
  • 财政年份:
    2021
  • 资助金额:
    $ 5.23万
  • 项目类别:
University of Colorado Cancer Center Support Grant
科罗拉多大学癌症中心支持补助金
  • 批准号:
    10371494
  • 财政年份:
    2021
  • 资助金额:
    $ 5.23万
  • 项目类别:
ETCTN Early Drug Development Opportunity Leadership program administrative supplement to Cancer Center Support Grant
ETCTN 早期药物开发机会领导计划对癌症中心支持补助金的行政补充
  • 批准号:
    10363981
  • 财政年份:
    2021
  • 资助金额:
    $ 5.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了